That the Parliament notes the Nuffield Trust's new report, The future for health after Brexit, published on 18 April 2024, which found that medicine shortages in the UK are being exacerbated by Brexit; understands that the report found that the number of warnings issued by drug companies about impending supply problems for certain products has more than doubled, from 648 in 2020 to 1,634 in 2023; further understands, with concern, that the report describes these medicine shortages as a "new normal", with the UK reportedly isolated in efforts to tackle problems in the supply chain due to policy choices by the UK Government, and with the UK being slower than the EU to approve new drugs that are authorised centrally, and believes that these issues are causing serious harm to Scotland's NHS and are a symptom of the unworkable nature of Brexit, which is backed by both the Conservatives and the Labour Party, and that they can only be realistically resolved by Scotland re-joining the EU as an independent country.